...

About Coltac Therapeutics

Central Israel
1-10
Min -
English
Biotechnology
Coltac is developing the next generation of molecular glues for protein degradation. Coltac is advancing 3 programs: 2 high-value oncology targets, and 1 non-oncology, all derived from our BOND+ platform: combining in-silico with proprietary bacteria-based, synthetic positive selection screening system for new molecular glues, allowing rapid transition from virtual screening to high-throughput, positive signal, bacterial validation. The company is backed by aMoon and IBF.

Coltac Therapeutics Internships

Start your journey
Coltac Therapeutics
Coltac Therapeutics

Why wait? Get started now

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Communication Preferences
Skip to content